Journal of Pharmacy and Pharmacology · 2018 · 15 citations · 33 references
MedicineNeurosciencePharmacologyMolecular NeuroscienceNeuropharmacologySynaptic PlasticityNeurogenesisNeuroprotectionNeuroprotective PharmacologyNeurotransmissionSynaptic TransmissionSynaptogenesisAdult Hippocampal NeurogenesisAmyloid-associated NeurotoxicityAmyloid-beta-induced NeurotoxicityDentate Gyrus FunctionHippocampal Neurogenesis RegulationPresynaptic SignalingProtective TreatmentsWestern Blot Analysis
OBJECTIVES: Considering the deleterious effect of Aβ1-42, a study was designed to evaluate the effect of phloretin on altered synaptic proteins and adult hippocampal neurogenesis in Aβ1-42-injected Wistar rats. METHODS: The rats were pretreated with 5 mg/kg p.o dose of phloretin and donepezil (positive control) for 28 days, followed by intrahippocampal injections of aggregated Aβ1-42. After termination, perfused brains were isolated and subjected to Western blot and immunohistochemistry (IHC) analysis. KEY FINDINGS: The Western blot revealed that Aβ1-42-injected rats had significantly low levels of synaptophysin as compared to sham control. Phloretin pretreatment significantly protected the presynaptic protein synaptophysin against the effects of Aβ1-42. There were no significant changes in the levels of PSD95 between different groups. The IHC findings showed that Aβ1-42 significantly reduced the Ki67 and DCX in the dentate gyrus as compared to sham control. However, phloretin significantly improved the number of Ki67- and DCX-positive neurons in the dentate gyrus region as compared to Aβ1-42 group. CONCLUSIONS: This study demonstrated the protective effect of phloretin on synaptophysin and adult neuronal proliferating cells in Aβ1-42-injected rats. The encouraging findings highlight the potential of phloretin as a dietary supplement targeting key therapeutic mechanisms in neurodegenerative disorders such as AD.
33
PSD-95 Involvement in Maturation of Excitatory Synapses
Alaa El-Husseini, Eric Schnell, Dane M. Chetkovich et al. · Science · 2000 · 1.3K citations
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Stephen W. Scheff, D. A. Price, Frederick A. Schmitt et al. · Neurology · 2007 · 841 citations